←Back to Expert Scholars
Translational Medicine / 转化医学Not-alpha IL-2 Variants
Kerry Chen
PhD
🏢Alkermes🌐USA
Principal Scientist, Cytokine Engineering
30
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Kerry Chen contributes to the development of next generation not-alpha IL-2 variants designed to favor CD8 and NK cells while limiting regulatory T cell expansion. Her work bridges structural biology and preclinical pharmacology. These programs aim to overcome the toxicity and immunosuppressive liabilities of classical IL-2.
Share:
🧪Research Fields 研究领域
IL-2 engineering
cytokine design
not-alpha IL-2
pharmacology
immunotherapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kerry Chen 的研究动态
Follow Kerry Chen's research updates
留下邮箱，当我们发布与 Kerry Chen（Alkermes）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment